3
IRUS Total
Downloads
  Altmetric

Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy

File Description SizeFormat 
Definitive ILVH 10.12.2019.docxAccepted version2.37 MBMicrosoft WordView/Open
Title: Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy
Authors: Finocchiaro, G
Dhutia, H
Gray, B
Ensam, B
Papatheodorou, S
Miles, C
Malhotra, A
Fanton, Z
Bulleros, P
Homfray, T
Witney, AA
Bunce, N
Anderson, LJ
Ware, J
Sharma, R
Tome, M
Behr, ER
Sheppard, MN
Papadakis, M
Sharma, S
Item Type: Journal Article
Abstract: Background and aims: Idiopathic left ventricular hypertrophy (LVH) is defined as LVH in the absence of myocyte disarray or secondary causes. It is unclear whether idiopathic LVH represents the phenotypic spectrum of hypertrophic cardiomyopathy (HCM) or whether it is a unique disease entity. We aimed to ascertain the prevalence of HCM in first-degree relatives of decedents with idiopathic LVH at autopsy. Decedents also underwent molecular autopsy to identify the presence of pathogenic variants in genes implicated in HCM through. Methods: Families of 46 decedents with idiopathic LVH (125 first-degree relatives) were investigated with ECG, echocardiography, exercise tolerance test, cardiovascular magnetic resonance imaging, 24h-Holter and ajmaline provocation test. Next generation sequencing molecular autopsy was performed in 14 (30%) decedents. Results: Decedents with idiopathic LVH were aged 33±14 years and 40 (87%) were male. Fourteen families (30%) comprising 16 individuals were diagnosed with cardiac disease, including Brugada syndrome (n=8), long QT syndrome (n=3), cardiomyopathy (n=2) and Wolff-Parkinson-White syndrome (n=1). None of the family members were diagnosed with HCM. Molecular autopsy in decedents did not identify any pathogenic or likely pathogenic variants in genes encoding sarcomeric proteins. Two decedents had pathogenic variants associated with long QT syndrome which were confirmed in relatives with the clinical phenotype. One decedent had a pathogenic variant associated with Danon disease in the absence of any histopathological findings of the condition or clinical phenotype in the family. Conclusions: Idiopathic LVH appears to be a distinct disease entity from HCM and is associated with fatal arrhythmias in individuals with primary arrhythmia syndromes. Family screening in relatives of decedents with idiopathic LVH should be comprehensive and encompass the broader spectrum of inherited cardiac conditions, including channelopathies.
Issue Date: 3-Feb-2020
Date of Acceptance: 4-Jan-2020
URI: http://hdl.handle.net/10044/1/76581
DOI: 10.1093/europace/euaa012
ISSN: 1099-5129
Publisher: Oxford University Press (OUP)
Start Page: 632
End Page: 642
Journal / Book Title: Europace
Volume: 22
Issue: 4
Copyright Statement: © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Sponsor/Funder: Wellcome Trust
St Georges University of London
Funder's Grant Number: 107469/Z/15/Z
13171-10
Keywords: Channelopathy
Hypertrophic cardiomyopathy
Left ventricular hypertrophy
Sudden death
Cardiovascular System & Hematology
1103 Clinical Sciences
Publication Status: Published
Online Publication Date: 2020-02-03
Appears in Collections:National Heart and Lung Institute
Institute of Clinical Sciences
Faculty of Medicine